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Turn this card for the inspiring story 
of agenerous legacy that still helps 
students at the School of Medicine. 
Support for today's students 
means a future of beneficial care 
and scientific breakthroughs. 







His generosity lives on 
"Under the will of the late Jackson Johnson, the sum 
of $250,000 was donated to the School of Medicine, 
the income of which is to be used to aid worthy and 
desirable students in acquiring and completing their 
medical education," 
With th is brief item in the 1930 Washington 
University School of Medicine Bulletin, so began the 
endowed Jackson Johnson Scholarship Fund, 
Jackson Johnson was president of International 
Shoe Company, the largest shoe manufacturer in the 
country early in the 20th century. He was elected to 
the Washington University Board ofTrustees in 1919 
and served until his death in 1929. He endowed the 
Jackson Johnson Scholarship Fund in memory of 
his son, Jackson Johnson Jr., wholost his life in "the 
Service of the United States during the Great War:' 
Coming during the Great Depression, these 

resources were critical in making it possiblefor 

aspiring young Students to pursue their medical 

educations. And for over 70 years, this scholarship 

fund has continued to do just that. Since its incep­

tion, more than 700 young men and women have 

received about $1 million in financial assistan ce , 

To maintain its reputation for excellence, 

Washington University School of Medicine must 

continue to attract the most promisingand best 

qualified students, Many of these exceptional 

students will require financial assistance, and the 

need for scholarship support is growing faster than 

available resources can sustain. 

To learn more about how you can 
make an impact, please contact the 

Office of Medical Alumni and Development 






SCHOOL OF MEDICINE 
St. Louis Children's Hospital PHOTO ESSAY 
The colorful, inviting atmosphere of St. Louis 
Children's Hospital helps put patients and 
their families at ease. 
Scratching the Surface 
1 
Study of a specific pain-senSing gene shows 
that pain and itching - long thought to be 

connected - are separate nerve functions. 
Critical Differences Count 
1 A faster, less-expensive method of identifying rare genetic variants in human DNA speeds the 
diagnosis and treatment of pediatric cancers. 
Safer Passage 
A new twist on a surgical instrument allows 
physicians to remove pituitary and other brain 
tumors without opening a patient's skull. 
COVER Alan L. Schwartz, PhD, MD, the 2 Pulse 
Harriet B. Spoehrer Professor of Pediatrics 
and head of the Department of Pediatrics at 24 Viewpoint
Washington University School of Medicine, is 
also pediatrician-in-chief at SI. Louis Children's 26 Alumni &Development 
Hospital. Schwartz stands in front of a colorful 
26 Scholarships
sculpture by the arti st Brother Mel Meyer, SM. 

For a glimpse of what makes Children 's a 28 Profile 

special place for care, please turn to page 8. 
 30 Class Notes 
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Simple skills tests may help with earlier detection of Alzheimer's 
new study of mental decline in 
the years prior to diagnosis of 
Alzheimer's disease suggests 
that changing the focus of testing may 
allow earlier detection of the disease. 
Current cognitive testing focuses on 
episodic memory, the ability to remember 
things like word lists or information from 
a reading. But scientists at the School of 
Medicine have found that another class of 
mental abilities, visuospatial skills, begins 
to deteriorate up to three years prior to 
diagnosis. These skills are tested with tasks 
such as connecting the dots or using a 
guide to build a structure with blocks. 
"We may need to rethink what we look 
for as the earliest signs of mental change 
associated with Alzheimer's disease;' says 
senior author James E. Galvin, MD, MS, a 
Washington University neurologist who is 
also on staff at Barnes-Jewish Hospital. "If we 
can better recognize the first signs of disease, 
we can start treating patients earlier, and 
hopefully with new treatments we can slow 
or perhaps even stop their progress into 
dementia:' 
2 Washington University School of Medicine 
The study results were published in the 
October 2009 issue of Archives ofNeurology. 
Galvin and his coauthors analyzed long­
term data from volunteers with the Memory 
and Aging Project at Washington University's 
Alzheimer's Disease Research Center (ADRC). 
For three decades, ADRC researchers have 
conducted extensive testing of volunteers 
to uncover factors associated with the nor­
mal, healthy retention of mental function in 
seniors. The new study analyzes data on 
444 volunteers ages 60 to 101 that were 
gathered between 1979 and 2006. 
Scientists categorized the new study's 
results into a global measure of cognitive 
abilities as well as three specific types of 
Psychometrician Molly Aeschlemann, left, conducts a 
trailmarking test with study volunteer Jan Bunch. 
mental skills: episodic memory, visuospatial 
skills and working memory - the ability 
to manipulate facts from memory, such as 
repeating a list of numbers backwards. 
Declines in episodic and working memory 
were discernible a year before diagnosis with 
Alzheimer's. Losses in the composite assess­
ment of cognitive abilities were detectable 
two years prior to diagnosis, and visuospatial 
skills began to decline three years earlier. 
The new perspective may allow doctors 
to detect signs of Alzheimer's earlier, but 
more information will be needed to make a 
firm diagnosis. To make that possible, ADRC 
researchers are correlating information 
from the new study with biomarkers, the 
physical changes associated with preclinical 
Alzheimer's disease. These include scanning 
the brain for amyloid plaques, a primary 
characteristic of Alzheimer's that can begin 
building in patients 10 years or more before 
clinical symptoms become apparent, or ana­
lyzing protein levels in the cerebrospinal fluid. 
"The new findings raise the question 
of what changes are occurring in the brain 
during the one- to three-year period prior 
to diagnosis;' Galvin says. "Patients have had 
plaques in their brain for years, and suddenly 
their cognitive abilities begin to deteriorate. 
Is a threshold being crossed where brain cell 
death begins to occur or really starts to pick 
up speed?" 
Winter 2009 
Federal recovery act aboon for 
research across multiple fields 
WUSTL among top 10 for NIH funds 
Washington University in St. Louis has been awarded nearly 
$80 million in funding from the 2009 American Recovery 
and Reinvestment Act (ARRA) to support research across a 
broad range of projects, including cancer, Alzheimer's disease, 
renewable energy, diabetes and climate change. 
As of September 30, the end of the federal fiscal yea r, 
175 university faculty members had received 207 awards. 
Some $73 million came from the National Inst itutes of 
Health (NIH); other awards came from the National Science 
Fou ndation and the Department of Energy. 
The largest chunk - $10 million - went to the Genome 
Center for a project to generate comprehensive genetic maps 
of mutations that underlie 20 types of cancer. Over time, the 
project is expected to lead to new ways to diagnose , treat or 
even prevent cancer. Other awards to School of Medicine 
researchers will support: 
o Testing an MRI-based 
heart-imaging technique that 
has the potential to deter­
mine whether heart mu scle is 
alive or dead more accurately 
than currently available tests. 
The technique offers unprec­
edented precision and may 
help to improve the effective­
.. ness of cardiac surgery. 
functional anomalies (red and yellow) Investigating ways to0 
diagnose Alzheimer's di sease before the onset of dementia by 
combining information from brain sca ns that image amyloid 
plaques - a key feature of Alzheimer's - with an analysis 
of key proteins in spinal fluid. Earlier diagnosis could allow 
patients to receive new treatments before the disea se causes 
irreversible brain changes that lead to memory loss. 
o Establishing a program that helps guide women in poor, 
minority communities in north St. Louis County through 
breast cancer screening and follow-up treatment, if needed. 
TIle awards have a significant economic impact in the 
St. Louis region. A recent survey by Families USA Foundation 
showed that every dollar of NIH funding to Missouri in 2007 
generated $2.09 of economic activity in the community that 
received the award. 
"By this estimate, recent stimulus funding to Washington 
University will generate well over $200 million in goods and 
services in our region," says Evan D. Kharasch, MD, PhD, the 
university's interim vice chancellor of research. "Moreover, 
research conducted with s timulus funds furthers our efforts 
to improve the lives of all people." 
outlook.wustl.edu 
Advanced heart imaging detects 
Solnica-Krezel new department head 
Lilianna Solnica-Krezel, PhD, has been chosen to head the 
Department of Developmental Biology. She succeeds interim 
head David M. Ornitz, MD, PhD, who has returned to ful1­
time research and teaching responsibilities after holding the 
position since October 2004. 
Solnica-Krezel comes to St. Louis from Vanderbilt 
University, where she was the Universi ty Professor and 
the Martha Rivers Ingram Professor of 
Developmental Genetics. She also is a 
professor of biological sciences, pediatrics, 
cell biology and phYSiology, and develop­
mental biology. 
In 2007, the Department of Molecular 
Biology and Pharmacology became the 
Department of Developmental Biology, 
reflecting a shift in research focus. During I· the past 15 years, the department has 
recruited researchers interested in embry­
onic development, aging, regenerative biol- Lilianna Solnica·Krezel, PhD 
ogy and phYSiology. Its focu s now encompasses an organism's 
development through life. 
Solnica-Krezel studies molecular and genetic mechanisms 
that control the early development of vertebrate an ima Is. 
She has studied this process in zebra fish, using a combina­
tion of genetic analysis with embryological and molec ular 
methods. She has received multiple research grants from the 
National Institutes of Health, March of Dimes Birth Defects 
Foundation and Human Frontier Science Program. 
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Institute of Medicine elects DeBaun 
iVlichael R. DeBaun, MD, has been elected to the Institute of 
Medicine of the National Academy of Sciences, one of the 
highest honors that U.S . medical scientists can receive. 
DeBaun, who holds the Ferring Family Chair in Pediatric 
Cancer and Related Disorders and is a professor of pediatrics, 
biostatistics and neurology, was recognized for his major 
contributions to the advancement of the medical sciences, 
health care and public health. 
He has established an internationally 
renowned program for treatment, educa­
tion and research into the complications 
of sickle cell disease. Under his leadership, 
a team of investigators received funding 
for the first NIH-sponsored international 
clinical trial in sickle cell disease. His 
research also has focused on determining 
the epidemiology, clinical significance 
and genetic basis for asthma and pain in 
children with sickle cell disease. 
DeBaun , who also is a pediatrician at St. Louis Children's 
Hospital, has initiated many community-based activities to 
improve the quality of life for individuals with sickle cell 
disease. These include a camp for children with the disease; 
the Charles Drew program, a cooperative effort with the 
American Red Cross to increase the number of African­
American blood donors; and Sickle Cell Sabbath, a faith­
based educational program about sickle cell disease, 
4 Washington University School of Medicine 
Michael R. DeBaun, MD 
Treatments improve outlook 
for pancreatic cancer patients 
Clinical trials examine drug reactions 
A team of surgeons and oncologists at the Siteman Cancer 
Center at Washington Universi ty School of Ivledicine and 
Barnes-Jewish Hospital is aggressively tackling pancreatic 
cancer - one of the dead liest forms of the disease - and 
conducting clinical trials of innovative treatment regimens, 
"The perception of 
video feature at: 
many people is that once mednews.wustl.edu 
you receive a diagnosis of 
pancreatic cancer there's not much that can be done, 
but that 's not true," says David C. Linehan, MD, associate 
professor of surgery. "We're attacking this very difficult 
disease from multiple angles; it 's a team effort. One of our 
areas of focus is ways to manipulate the immune system so 
that it can fight the tumor." 
Their latest clinical endeavor yielded promising results by 
including the immune-system stimulator interferon along 
with chemotherapy and radiation in patients who had their 
pancreatic tumors surgically removed, In a study published 
in the Annals afSurgery, the team reported that the three­
year survival rate was 41 percent for patients on this regi­
men. In comparison, typical three-year survival rates are 
about 30 percent. 
Linehan and colleagues are part of the largest regional 
surgical referral center for disorders of the liver, gallbladder, 
pancreas and GI tract. Many of their patients have survived 
five or more years after diagnosis, The team is continuing to 
initiate new trials for pancreatic cancer and plans to start a 
second trial of interferon-based therapy to attempt to reduce 
adverse reactions by altering time and dosage, 
Becker honored for leadership role 
Bernard Becker, MD, who headed the 
School of Medicine's Department of 
Ophthalmology and Visual Sciences 
from 1953 to 1988, is this year's 
recipient of the American Academy of 
Ophthalmology's highes t honor: 
the 2009 Laureate Recognition Award. 
Becker, lecturer and professor 
emeritus, was recognized for his 
pioneering efforts in research, clinical 
care and education, 
Bernard Becker, MDUnder his tenure, the department 
became internationally recognized for exceptional research 
and teaching, Many residents who trained with Becker now 
serve as department heads or hold other prominent pOSitions 
in academic ophthalmology throughout the world. 
Winter 2009 
OPHTHALMOLOGY AND VISUAL SCIENCES 
Out ofthe darkness and into the light 

E ver wonder how your eyes adjust during a blackout? When we go from light to near total darkness, 
cells in the retina must quickly adjust. 
Vision scientists at the School of Medicine 
have identified an intricate process that 
allows the human eye to adapt to darkness. 
The same process also allows the eye to 
function in bright light. 
The discovery could contribute to better 
understanding of human diseases that affect 
the retina, including age-related macular 
degeneration. That's because the disease 
and the pathway that researchers identified 
involve the same cells called cone cells. 
"Age-related macular degeneration may 
be modulated, perhaps, through this path­
way we've identified in the retina;' says prin­
cipal investigator Vladimir J. Kefalov, PhD. 
"Deficiencies in this pathway affect cone 
cells, and so does macular degeneration, so 
it's possible that if we could enhance activ­
ity in this pathway, we could prevent or 
reverse some of that damage to cone cells." 
The retina's main light-sensing cells 
are called rods and cones. Previous animal 
studies showed that cones rely on light­
sensing molecules that bind together to 
make up visual pigments. The pigments are 
destroyed when they absorb light and must 
be rebuilt, or recycled, for the cone cells to 
continue sensing light. When this recycling 
was prevented, the rods no longer worked, 
but the cones continued to function. This 
made it clear to the researchers that a 
second pathway was involved. 
To determine what made this possible, 
Kefalov's team focused on Muller cells, a 
i'particular cell type in the retina that sup­ Iports and interacts with rods and cones. 
They destroyed the Muller cells in animal 
models, then exposed the retina to bright 
light, followed by darkness. "When we did 
this, the retinal visual pathway could not 
function because cones ran out of photo­
pigment and could not adapt to dark:' ). 
The results, published in the October 13, i· 
2009 issue of Current Biology, suggest that I 
Muller cells are key to this pathway in mam­

mals, including humans. When those cells 

function properly, cones are able to func­

tion in bright light and adapt to darkness, t 

independently of the pigment epithelium. 
 I 
This discovery means it may one day 
be possible to manipulate this pathway in l' 
the retina to improve vision when the other f', 
pathway, involving pigment epithelium, 

has been interrupted by injury or disease. I 
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Milbrandt named genetics head 
Jeffrey D. Milbrandt, MD, PhD, has been named head of 
the Department of Genetics and the James S. McDonnell 
Professor. He succeeds interim head Susan K. Dutcher, PhD, 
who had held the position since June 2006. 
Milbrandt, who joined the School of Medicine faculty in 
1983, brings a strength in basic and translational science to 
the position and an appreciation of the expanding role of 
genetics in the diagnosis, prognosis and treatment of disease. 
As head of genetics, he hopes to bolster faculty collaborations 
with researchers in clinical and preclinical 
departments and encourage investigations 
that utilize genetic analysis to understand 
basic mechanisms of disease. 
The department is widely recognized 
for its study of fund amental genetic 
mechanisms that underlie biological pro ­
cesses. The department also includes the 
world-renowned Genome Center, whose 
scientists played a leading role in the 
Human Genome Project. More recently, 
Jeffrey D. Milbrandt, MD, PhD these scientists have pioneered the decod­
ing of cancer patients' genomes to identify genetic changes 
at the root of the disease. Computational biologists in the 
depar tment are highly regarded for their study of complex 
genetic networks and the statistica l analysis of genetic data. 
Milbrandt's own research has focused on neuronal 
signaling cascades stimulated by neurotrophic factors and 
on understanding how glial cells contribute to axonal 
regeneration after nerve injury. 
6 Washington University School of Medicine 
Multinational effort to study 
Hispanic health and disease 
Mortality, economic impact are focus 
The Prevention Research Center (PRC) in St. Louis is launch­
ing a multinational research project focused on preventing 
the leading causes of death in Hispanics in the United States 
and Latin America. The project is funded by the Centers 
for Disease Control and Prevention's National Center for 
Chronic Disease Prevention and Health Promotion . 
The PRC in St. Louis, a collaboration between Washington 
University and Sa int Loui s University, will conduct a four­
year, $2.8 million effort to apply and adapt evidence-based 
strategies for preventing heart disease, cancer, diabetes and 
obesity in the United States, Mexico and Brazil. 
"By understanding strategies for physical activity promo­
tion that work in Latin America, we will be better able to 
address the needs and prefer­
ences of Hispanic populations 
in the United States," says Ross 
C. Brownson, Ph D, project 
director and professor at the 
university 's School of Medicine 
and the George Warren Brown 
School of Social Work. 
Chronic diseases are a grow­
ing challenge for public health 
in Latin America and globally. Physical education taught in public 
In Brazil, chronic diseases such spaces improves community health. 
as heart attack and stroke are leading causes of mortality, 
generating premature deaths and economic burden. 
In a previous phase of this project , PRC researc hers evalu­
ated evidence from physical activity interventions carried out 
in community settings in Recife, Brazil. Physical education 
instructors there taught free calisthenic and dance classes 
in public spaces, led walking groups and provided nutrition 
information. Scientists determined that the project greatly 
increased physical activity among community members. 
In the project's current phase, researchers will dis­
seminate results from the previous study to communities, 
in st itutions and public health professionals in Brazil and 
across Latin America. They also may teach school adminis ­
trators and public health and medical professionals the latest 
approaches to physical activity as well as evaluate innovative 
exerc ise programs in schools and parks in Brazil. 
"We hope this new program will build on what we have 
a lready learned," says Brownson, also a faculty scholar 
of Washington University 's Insti tute for Public Health. 
"Coupled with healthy eating, physical activity can help 
prevent and control diabetes , hypertension and heart 
disease, resulting in improved quality of life and health." 
Winter 2009 
NEUROLOGY 
ALS model mirrors human disorder 

A ew mouse model of amyotrophic lateral sclerosis (ALS) closely resembles the paralyzing 
disorder in humans, researchers at the 
School of Medicine reported in the 
November 3,2009 issue of Proceedings of 
the National Academy ofSciences. 
Like humans with ALS, the mice studied 
develop progressive paralysis; lose muscle 
mass and specific types of motor neurons, 
which are nerve cells that control muscles; 
and die of the disorder, which is currently 
fatal in humans. 
"As far as we know, this is the first 
mouse model that recapitulates 'typical' 
ALS to be produced in more than a decade," 
says senior author Robert H. Baloh, MD, 
Ph D, assista nt professor of neu rology. "That 
could make it very helpful for our efforts to 
better understand and identify treatments 
for this terrible disorder:' 
The mice have a point mutation or 
single letter of erroneous DNA code in 
the gene for a protein called TDP-43. 
outlook.wustl.edu 
Washington University scientists Nigel 
J. Cairns, PhD, and Alison Goate, PhD, 
sequenced a point mutation in the TDP-43 
gene of a St. Louis family with an inher­
ited form of ALS, and Baloh's lab created a 
mouse line with the family's mutation. 
"TDP-43 is only the second gene to be 
linked to an inherited form of ALS that 
appears clinically identical to sporadic ALS, 
and it's very promising that this similarity 
The utility of this model 
to mirror human ALS 
should aid development 
of better treatments. 
allows the symptoms of sporadic ALS to be 
accurately modeled in mice;' Baloh says. 
While mice typically live more than two 
years, mice with the TDP-43 mutation live 
only five months. Like humans, the mice 
develop problems with walking, lose mus­
cle mass and eventually become paralyzed. 
In addition to helping researchers under­
stand what causes some forms of ALS, the 
new mouse model may provide an impor­
tant tool for screening new drugs. Scientists 
already have another mouse model of ALS 
with a mutation in SOD1, the first gene to 
be linked to an inherited form of ALS with 
typical symptoms. However, according to 
Baloh, it hasn't always been the best tool 
for predicting whether treatments will work 
in humans. 
"If we use the two models together 
to test potential treatments, that might 
provide us with a much finer screen;' says 
Baloh. "This could help relieve some frus­ '­
tration in the field, because there are a 
number of new drugs ready to be tested r 
in humans, and we urgently need ways to 
determine which should be tried first:' 
The TDP-43 mice also have brain dam­
age similar to patients with frontotemporal 
dementia, a disorder sometimes associated 
with ALS. Baloh and colleagues will use the 















While studying a 
specific gene for 
pain, researchers 
happened upon an 
explanation for itch 
that could lead to 
better chronic itch 
management 
BY JIM DRYDEN 
( 
As native St. Louisan and baseball philosopher Yogi Berra once said: 
"You can observe a lot just by watching." Although he never heard 
Berra's famous "Yogi-isms" while growing up in China, Zhou-Feng 
Chen, PhD, has followed the former catcher's sage advice anyway. 
Chen decided that if he wanted to learn whether an animal is itchy, 
an easy way to find out would be to watch and see whether the animal 
scratches. So for the last couple of years, Chen and others in his labora­
tory have spent a good deal of time watching mice scratch. 
It all began when Chen, an associate professor of anesthesiology, 
psychiatry and developmental biology was trying to learn more about 
pain sensation. His laboratory was looking for genes in the spinal 
cord that might be related to the pain response. Itch also was involved 
because historically, scientists had thought of the itch response as being 
a slightly less intense version of pain and that both sensations were 
transmitted through the same neural pathway. 
That's what it said in the neurology textbooks, anyway. As it turns 
out, those textbooks were wrong. 
While searching for genes related 
to pain, Chen's lab began studying a 
gene called GRPR (gastrin-releasing 
peptide receptor). Among the poten­
tial pain-sensing genes they identified, 
GRPR stood out because it was active on 
a relatively small number of nerve cells in 
the spinal cord. 
To get an idea of what the gene was doing, they 
studied mice without the GRPR gene to learn how they were 
different from normal animals. 
"At first, we were a little bit disappointed," Chen says, 
"because the mice without a GRPR gene seemed to react to 
painful stimuli in the same way normal mice did." 
But then they injected the normal mice with a substance 
that stimulates GRPR, and the mice started to scratch. 
of the neurotoxin caused the mice 
to scratch 80 percent less and, in 
some cases, eliminated scratching 
altogether. 
Further tests on the mice showed 
that other neurologiC functions, such 
as motor control, were not affected when 
GRPR-expressing neurons were destroyed. 
But, as with the mice without GRPR, the pain 
response wasn't affected. "This finding has very important 
implications for therapy," says Chen, who also is an investi­
gator at Washington University's Pain Center. "We've dem­
onstrated that GRPR functions on specific neurons that are 
critical for itching, but not for pain." 
The ability to separate pain sensation from itch suggests 
that it may be possible to treat itch with drugs that don't 
"That's when we thought the gene might be 
related to itch sensation," Chen says. "So we 
began to look carefully at the itch response in 
mice with and without GRPR." 
They studied itching by watching the 
mice scratch, and the researchers found 
that the normal mice scratched vigorously 
when exposed to a variety of itch-producing 
substances. The mice without GRPR, on 
the other hand, scratched less. 
But when either strain of mouse was 
exposed to painful stimuli, such as an injec­
tion, the mice without GRPR withdrew and 
licked themselves just like the normal mice. 
So, although they reacted very differently 
to itchy things, they both avoided pain and 
reacted to painful stimuli in identical ways. 
The ability to 
separate pain 
sensation from itch 
suggests that it may 
be possible to treat 
itch with drugs that 
don't alter the pain 
response. 
alter the pain response, and vice versa. 
That's important because pain can be an 
important protective cue that warns of 
danger, says Alex S. Evers, MD, the Henry 
E. Mallinckrodt Professor and head of 
the Department of Anesthesiology. "This 
means that potentially we can design 
agents that selectively block out the 
pruritic side effects of pain-killing drugs, 
particularly opiates," says Evers. "This 
could be important in allowing better 
analgesic therapy in a variety of situations 
from cancer pain to labor pain." 
Itching is a common side effect of 
painkillers like morphine, and treatment 
options for itchy patients have been lim­
ited. But Chen's team already has decou­
From that behavior, Chen was able to recognize that pain 
and itch were not two parts of the same response, but were 
different responses altogether. 
This told the researchers that GRPR was helping to 
regulate itch and, because the gene was functional only on 
a small number of neurons, Chen's team zeroed in on those 
particular cells to see whether they made up an itch-specific 
pathway in the spinal cord. 
In the September 18,2009 issue of the journal Science, 
Chen reported that such a pathway was likely. Unlike the 
earlier experiments involving mice without GRPR, this time 
Chen's team injected the spinal cords of normal mice with a 
neurotoxin called bombesin-saporin. The neurotoxin binds 
to GRPR, and it killed the neurons that had a functional 
GRPR gene. 
Then they looked at the mouse behavior again. When the 
mice injected with bombesin-saporin were exposed to things 
that caused itching, they didn't scratch. An appropriate dose 
pled itching induced by opiates from pain control in mice. 
"If we inject a GRPR inhibitor and morphine into the 
spinal cord in the mouse, the drug continues to have its 
analgeSiC effect, but the mice don't scratch," Chen says. 
"That proVides still more evidence that analgeSia and itching 
can be separated." 
Many human patients with chronic pain receive spinal 
perfusions of opioid drugs to control their pain. Perhaps, 
Chen says, one day those patients may receive the opioid 
drug along with a second drug that inhibits GRPR so that 
they can enjoy the benefit of pain relief without the side 
effect of itching. 
Chen is now working to characterize the itch-specific 
neuronal pathway. He's also studying GRPR-expressing 
neurons in the spinal cord, looking for other genes that may 
be related to the itch response. Meanwhile, he continues to 
keep an eye on his mice because, after all, you really can 
observe a lot just by watching. SEE GRAPHIC NEXT PAGE 

1\n~it{h reiaYi GRP 
receptor-expressing -' 
neurons (dark spots) 
within the spine 
major motivation behind the $3 billion project 
to decode the human genome was that it would 
enable scientists to sift through the sequence 
of letters that make up DNA to find common 
changes that predispose individuals to 
common diseases, such as cancer, diabetes or Alzheimer's. 
But this first step toward personalized genomic medicine 
has turned out to be far more complex than expected. 
Many genetic studies have compared common variations 
in the DNA of healthy people and sick patients, finding dozens 
of changes linked to diseases. But variations identified to date 
account for only a small percentage - typically 1 percent to 
3 percent - of overall genetic risk for any particular disease. 
That disappointment has led a growing number of 
scientists to suspect that rare genetic variants lie at the root 
of many common diseases. But short of sequencing the com­
plete genomes of many thousands of individuals - a highly 
expensive and time-consuming task even with the latest 
DNA sequencing technology - no reliable method exists to 
identify rare variants or interpret their influence on disease. 
"There's intense interest in rare variants right now," says 
pediatric oncologist Todd E. Druley, MD, PhD. "We couldn't 
wait until whole-genome sequencing became cost effective 
before we started our search." 
The urgency hits home every time Druley has to tell par­
ents their child has cancer. "Of course, the first thing parents 
want to know is whether their child will die. Then, invariably, 
they ask: 'Why did this happen to my child?'" 
Not knowing the answer was the driving force behind 
Druley's efforts to find a way to search for rare variants. 
Toward that end, he teamed with Robi D. Mitra, PhD,Critical 
e ffierenCeaSSis",nt pCOf'~~:~;::::~~:~:~~:[:~i~:~~~~~::" to 
collect large volumes of genetic data. 
"We think children with cancer are likely dI to have a unique collection of rare, inherited 
DNA variations that predispose them to their 
disease or to difficulties metabolizing the medications used to 
treat cancer," Mitra says. "Rare variants likely contribute tocount disease in adults, too, but until now, we haven 't even had a 
way to investigate the link." 
With funding from the Children's Discovery Institute, theA highly efficient - and effective ­ team developed a way to find and quantify all the inherited 
method for finding disease-related genes 	 rare genetic variants in a complete set of human genes. Their 
method is fast and inexpensive - and incredibly accurate, takes a shortcut via complex math 
they reported in the April 2009 issue of Nature Methods. 
The approach, which combines next-generation DNA 
sequencing technology with a computer program theBY CAROLINE ARBANAS 
research team developed, has attracted the attention of other 
scientists. The team now is working with the Children's Photo above, from left: Todd E. Druley, MD, PhD, Oncology Group, the global clinical trials cooperative, to Robi D. Mitra, PhD, and Fran(es(o Vallania identify rare variants in pediatric cancer patients with an 
aggressive form of leukemia . 
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Qj,d,s (E) = 2-nj ,d,sD(Pj ,d,sIlQj,d,s) 
Adapting Sanov's theorem resulted in a more efficient variation-finder. 
Doing the math 
The question was how In order to distinguish a 
to tell an unusual gene real SNP from sequencing 

from a technical glitch. noise, the research team 

Researchers sought to developed a novel algorithm 
determine variations that based on an application of 
altered a single letter in the Sanov's theorem, which was 
genetic code (A, C, G or T), borrowed from the field of 
called single nucleotide information theory. 
polymorph isms (SNPs). This An added mathematical 
problem becomes really model of known error rates 
challenging when looking aided comparisons with the 
at rare genomic variation observed genetic variations. 
because SNPs largely The result: accurate and 
overlap with background more efficient detection of 
errors generated d uri ng rare SNPs down to 1 mutation 
the sequencing process. in 1,111 individuals. 
SNPs (red) align with expected errors (blue) in this detail of a larger graph. 
T he bulk of the 3 billion pairs of chemical bases that 
make up DNA - represented by the letters A, T, C 
and G - are identical from one person to the next. 

But the exact order of the letters varies, often at a single 
location, in some 10 million common spots in the genome. 
These variations are what make each individual unique. 
Each person also has about 300,000 rare genetic alterations 
buried within the genome. These variations mean nothing by 
themselves; it's only in the context of a large group that scien­
tists can identify their links to a particular disease. 
To find individual DNA samples to search for rare variants, 
Druley and Mitra turned to F. Sessions Cole, MD, the Park J. 
White MD Professor of Pediatrics and director of the Division 
of Newborn Medicine, who provided his collection of thou­
sands of blood samples collected from the heels of newborns. 
The researchers pooled the DNA of 1,111 newborns and 
targeted four genes. To ensure accurate results, they created 
thousands of copies of the four genes and sequenced them 
many times to identify the full spectrum of genetic variation. 
TIle genes of interest included surfactant protein B, wbich 
Cole discovered in 1993 and linked to respiratory distress 
syndrome in infants. Cole had painstakingly sequenced the 
gene in all 1,111 individuals with traditional sequencing 
methods; Mitra and Druley used the gene as a control. 
"We wondered whether we would find the same variants 
at the same frequencies in our pooled sample that Dr. Cole 
had already identified," Mitra says. 
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They also looked for rare variants in two genes important 
in cancer - p53 and APC - as well as in beta actin. None of 
these three genes had been sequenced in the 1,111 individuals. 
In all, the team sifted through a haystack of 4.5 billion 
DNA bases. TIley found 64 variants in the four genes, nearly 
two-thirds of which were identified in less than 1 percent 
of the individuals, making them rare. These included four 
variants that had not been previously identified . Three of 
them occurred in the two cancer genes. 
The computer algorithm, developed in collaboration 
with graduate student Francesco Vallania, accurately distin­
guished between rare variants and sequencing errors most 
of the ti me. "This is crucial because rare variants can easily 
look like sequencing errors," Mitra says. "How do you tell 
the difference? The algorithm we developed could do that." 
The researchers accurately recapitulated all of Cole's data, 
finding variants at the predicted frequencies in the surfactant 
protein B gene. They also went back to verify the frequencies 
of variants in the otber three genes. In all, they accurately 
identified all the rare variants in the pooled sample. They 
also identified sequencing errors as mistakes 99.S percent of 
the time. Overall , the algorithm was 96 percent accurate. 
With the new method, the sequencing that took Cole 
2.5 years at a cost of $200,000 was completed in just four 
months for $6,000. 
"This provides proof of principle," Druley says. "We're 
now testing the approach in children with aggressive leuke­
mia and in healthy children to see whether we can find 
rare variants linked to the disease." 
Ideally, the team hopes to identify rare variants linked 
to prognosis that could be evaluated in newly diagnosed 
patients. These variants may tell doctors which patients 
need aggressive therapy or which treatment works best in 
a particular patient.Rare genes, found faster Since the original 
publication, they FULL-GENOME COMPARISON have expanded theirSEQUENCE METHOD 
approach by adding2.5 years 4 months a DNA barcode onto 
$200,000 $6,000 each individual's con­
tribution to the pooled 
DNA sample. This enables them to trace rare variants back 
to individual patients, which was not previously possible. 
The investigators also are collaborating with other 
Washington University researchers by using the method to 
find rare variants in other complex diseases: newborns with 
lung disease, children witb clubfoot, brain tumors or sickle 
cell disease, adults with heart failure and lung disease. 
"Ultimately, we think we' ll be able to use this simple 
method to find important genetic variations," Mitra says. 
"Lots of people have done genetic studies and have come up 
empty-handed. They're anxious to get at rare variants, and 
we think this method will get us there, not just for cancer 




Even though brain surgeons perform pituitary 
surgery, the pituitary gland isn't really part of the 
brain. The pea-sized gland nestles in a protective 
bone cavity in the center of the head, directly 
beneath the brain. That puts it right next to critical 
arteries, nerves and brain regions, making pitu­
itary surgery a very delicate operation indeed. 
By far, the most common reason for pituitary 
surgery is to remove benign tumors ca lled pituitary 
adenomas, which account for about 15 percent 
of brain tumors. If these grow large enough, they 
can cause headaches and dizziness or press on the 
optic nerves and lead to vision problems. 
The pituitary is a hormonal jack-of-all-trades, 
sec reting hormones that help regul ate growth, 
blood pressure, reproductive functions, energy 
metabolism, fluid balance and body temperature. 
Pituitary adenomas can increase or decrease pitu­
itary hormone production, lead ing to disorders 
like Cushing's sy ndrome, which is characterized 
by weight gain, high blood pressure and other 
health issues, gigantism, en larged thyroid , 
inappropriate milk produc tion and many others. 
During pituitary tumor surgery, doctors have 
to take care to avoid injury to the carotid arteries 
running on either side of the pituitary and to the 
membrane covering the brain, which is directly 
behind the pituitary. Damaging the healthy 
portions of the pituitary during surgery could 
harm hormone production. 
The bone cradling the pituitary si ts right at 
the back of one of the nasal sinuses. So most of 
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the time, surgeons can reach pituitary tumors by 
go ing through these sinuses instead of opening 
the sk ull and moving aside brain tissue. 
For this kind of pituitary tumor operation, 
Chole and Dacey divide tasks. Chole starts the 
procedure by cutting through or removing bone 
and cartilage struc tures within the nasal sinu ses 
to expose the bone covering the pituitary. Then 
Dacey goes in to exc ise the tumor. 
Until recently, it was routine to get to pituitary 
tumors through an under-the-lip , or sublabial, 
approach. 111at involves pulling up the upper 
lip and making incisions under it to get to the 
sinus cavities. 
Unfortunately, after such operations , patients 
might have lip swelling, as well as lingering numb­
ness of the upper front teeth and lip. Sometimes 
patients' dentures don't fit well after the surgery 
and have to be remade. Packing the area with 
absorbent materials to prevent bleeding and fluid 
lea kage often causes face and head pain during the 
recovery period. 
To alleviate those problems, Chole and Dacey 
started performing the operation by entering the 
nasa.! cavity through a nostril and then going into 
the sinus cavities at the back of the nasa l cavity. 
At times, neurosurgeons perform this surgery 
without a retractor, but many sit uations ca ll for 
use of the inst rument. Unfortunately, he found 
that available retractors weren't all that practical 
for doi ng this procedu re th rough a nostri l. 
Winter 2009 
The main component of pituitary retractors 
is something that looks like a metal tube, about 
three to four inches long, split lengthwise; the 
halves of this tube are called blades. Attached to 
one end of the blades at a right angle are handles 
that allow surgeons to manipulate the instrument 
and to spread the two blades apart. The blades 
hold tissues out of the way a nd give surgeons a 
clear pathway to insert implements for cutting 
out the tumors. 
"We started doing through-the-nose surgery 
with existing instruments ," Chole says. "But we 
found they didn 't angle correctly and the size 
was wrong. We could get by most of the time, 
but the view of the pituitary wasn't as good as 
we wanted ." 
So, in his home workshop, Chole made new 
blades for one of the standard retractors. These 
new blades had an upswept curvature at the end 
and a subtle flaring that made it easier for the 
surgeons to reach upward to the pituitary and 
push aside adjacent tissue. Chole also made the 
blades small enough to fit through a nostri I. 
That patched-together instrument was better, 
but the surgeons found a few more ways to 
improve the design. Working with instrument 
manufacturing company Anspach, Chole and 
Dacey have developed a final product, a stainless 
steel pituitary retractor with aluminum blades 
in three sizes suitable for children and small 
and large adults. The company will market 
the device. 
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Their completed retractor design is unique in 
allowing the blades to move in two ways: opening 
in parallel or opening at an acute angle. It also 
has a bar that rests on the patient's forehead to 
s tabilize the instrument. 
The retractor can grip on to an endoscope, a 
lighted tube with a wide-angle lens . The endoscope 
can be fed through the retractor and back to the 
area of the tumor. But it a lso can be moved aside 
so it doesn't get in the way of the surgical instru­
ments needed to take out the tumor. 
"Because the retractor can hold an endoscope, 
that fre es a surgeon from having to hold it," Dacey 
says. "111e retrac tor also makes it easier to go back 
and forth between using an endoscope and using 
an operative microscope to see the tumor. It's also 
very good that the retractor is adjustable to allow 
us to deal with an individual patient's anatomy." 
Patients are Iikely to be pleased at the chance 
for pituitary surgery with fewer complications 
and no external stitches or scarring. Chole says 
one patient was surprised when he awoke from 
anesthesia after a recent operation. 
"He felt so good," Chole says , "that he accused 
us of not doing the surgery at all." 0 
The completed 




small and large 
adults - will 
be marketed. 
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The Ochieng brothers wanted 
nothing more than to be 
physicians. Little did they 
realize that their dedication 
to giving back would bring 
them to the attention of the 




WO BROTHERS FROM KENYA 
say they owe much to their home village of Lwala, 
a community that has supported them throughout 
their educational careers. In turn, the brothers 
wanted to give back to Lwala and, at the same time, honor 
their parents, Erastus and Margaret, who had both died 
from complications of HIV/AIDS. While studying in the 
United States, both Milton, an internal medicine resident at 
Barnes-Jewish Hospital and Washington University School 
of Medicine, and Fred, a medical student at Vanderbilt 
UniverSity, worked tirelessly to raise funds to build a health 
clinic in Lwala. The Ochieng Memorial Lwala Community 
Health Center opened in 2005; to date, more than 32,000 
patients have been treated there. "For us," says Milton, "it's 
been realizing that every ounce of our energy - every extra 
second we spend answering an e-mail, making a phone call, 
or giving a talk somewhere - can translate to a life saved." 
an 
St. Louis premiere event 

The red carpet was unfurled on November 3 at the Missouri Botanical 
Garden to showcase "Sons of Lwala," a moving documentary that 
examines the challenges and triumphs of Milton Ochieng, his 
brother, Fred, their friends, family and fellow villagers in building 
a health clinic in their hometown of Lwala, Kenya. Washington 
University School of Medicine, learn more and view the trailer at: 
Barnes-Jewish Hospital and others Iwalacommunityalliance.org 
partnered to host the viewing. 
The film, directed by Barry Simmons, chronicles the journey of the 
brothers, who left Lwala to attend college and then medical school 
in the United States, but never forgot their impoverished village. 
The Ochieng Memorial Lwala Community Health Center they 
founded is the first medical facility in Lwala, a village that has no 
electricity or running water. 
Proceeds from the sale of the documentary support the Lwala 
Community Alliance in sustaining existing programs and developing 
new initiatives, such as a maternity program and medical training. 
Overall, the Alliance works to empower the people of Lwala by 
providing jobs, training, education and improved health. 
Far left: Kenneth S. Polonsky, MD, 
Busch Professor and head of the 
Department of Internal Medicine, 
left, and Melvin S. Blanchard, MD, 
associate professor and director of 
the department's residency pro­
gram. Left: Kenyan ambassador 
Peter Ogego, center, with Fred 
Ochieng, left, and Milton Ochieng. 
The Ochieng brothers 
pose with School of 
Medicine volunteers 
who raised nearly 
$20,000 at the movie 
premiere for the Lwala 
Community Alliance, 
agroup that works to 
advance the physical 
health, educational.~ 
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Financial tipping point 
Scholarships help future medical professionals train to serve others 
For many students, receiving a scholarship to Washington University School of Medicine represents a tipping point - that critical moment when a person arrives at a decision. A scholarship provides an extraordinary 
opportunity to train at an acclaimed institution alongside 
world-class scientists, physicians and health care profession­
als. It also represents faith in individuals and their futures . 
Students who enroll at Washington UniverSity School of 
Medicine come from diverse ethnic, geographic, economic 
and social backgrounds. They arrive on campus with dis­
tinct professional goals and career aspirations, while being 
bound together by a common desire to heal the patients that 
they will serve later in their careers. It is this unique balance 
between the dissimilar and similar that enriches the robust 
academic environment in which all students train as physi ­
cians, research scientists, physical therapists, occupational 
therapists and audiologists. 
"1 want to practice medicine in underserved and under­
developed areas," explains Joseph B. Song, a first-year 
medical student. "However, the cost of a medical education 
presented a Significant hindrance." Song received a scholar­
ship to attend Washington University and plans to pursue 
his goal to practice in underserved areas. He is getting a 
head start through his involvement in community outreach 
efforts offered at the School of Medicine. 
Many students at Washington University have simi­
lar stories. More than 70 percent of students currently 
receive scholarship support during their academic career. 
Scholarships, in combination with student loans, enable 
many students to attend Washington University School of 
Medicine and fulfill their tremendous potentiaL 
"Washington University has enjoyed wonderful success 
in its ability to recruit many outstanding students to the 
School of Medicine and our top-ranked Programs in 
Audiology and Communication Sciences, Physical Therapy 
and Occupational Therapy," says Larry J. Shapiro, MD, 
executive vice chancellor for medical affairs and dean of 
Washington University School of Medicine. "Despite our 
past success, we must continue to find ways to lessen the 
overwhelming financial burden challenging our students." 
26 Washington University School of Medicine Winter 2009 
Opening Doors to the Future 
The Scholarship Initiative for Washington University School ofMedicine 
Q: How much student financial aid 
was provided in 2009-1 O? 
A: More than $15 million. Of this, 
scholarship support exceeded $6 million. 
Q: What is the average student debt? 
A: Medical students graduate with 
an average debt exceeding $100,000. 
Students in the Programs graduate 
with average debts ranging from 
$85,000 to $96,000. 
Q: Who will receive my scholarship? 
A: You may direct your scholarship to 
support students in medicine, audiology 
and communication sciences, occupa­
tional therapy or physical therapy. 
Q: What are the giving options? 
A: Giving options include an annual 
scholarship with a single gift or an 
endowed scholarship with a gift that 
is invested and provides income in 
perpetuity. Giving methods include out­
right gifts of cash or securities, mUlti-year 
pledges, and planned gifts including 
estate and life-income gifts. Donors may 
name their annual or endowed scholar­
ships to honor themselves, their family, a 
friend, a current or former faculty member, 
or in memory of a loved one. 
For more information, please contact 
Pamela Buell at 314-935-9691. 
Opening doors to the future 
The need for scholarships is significant and expected to 

increase in the years ahead, which is why Washington 

University has launched Opening Doors to the Future: 

The Scholarship Initiative for Washington University. 

This five-year efFort was formally launched on November 7, 

2009, in conju nction with Founders Day and is designed to 

augment support for student scholarships. 

The School of Medicine efFort, led by co-chairs Gordon 
W. Philpott, MD 61, and Jay Kaiser, MD 72, has a goal of 
$25 million and will be part of the university-wide goal of 
$150 million. Through this effort, the School of Medicine 
has enlisted the help of alumni who have seen the tangible 
benefit of scholarships. As volunteers, they will assist the 
School in its efForts to boost scholarship support for students. 
"TIle students who come to Washington UniverSity are of 
exceptional ability. Scholarship support is often the decisive 
factor that enables so many of these talented individuals to 
achieve their true potential," observes Philpott. 
"Scholarships allow students to pursue careers based 
on passion and not financial circumstances," adds Kaiser. 
"TIle Scholarship Initiative will ensure that current and 
future students have the same opportunities that we had 
as students." 
Broadening the margin for excellence 
The scholarships that are offered by Washington UniverSity 
School of Medicine comprise both endowment income and 
annual contributions from alumni, friends and organiza­
tions and have enabled the school to recruit the nation's best 
students for more than a decade. Many of the other leading 
medical schools are quickly clOSing the gap. These institu ­
tions possess endowments that surpass that of Washington 
University School of Medicine, and they are able to offer 
larger scholarships to the most outstanding students. 
The Scholarship Initiative will help to maintain and 
expand Washington UniverSity'S competitive edge as well 
as keep profeSSional education affordable for a greater 
percentage of students. 
Annual scholarships will offer opportunities to students 
currently enrolled at the School of Medicine, wbile endowed 
scholarships provide support for students who will study 
here now and in future years. Regardless of the type of 
scholarship a donor chooses, the students will benefit. 
The cost of excellence 
During the 2009-10 academic year, the School of Medicine 
awarded more than $15 million in financial aid to its 
students, including tbose enrolled in the Programs in 
Audiology and Communication Sciences, Physical Therapy 
and Occupational Therapy. Of this total, scholarship support 
exceeded $6 million. 
And yet, the burden of debt remains daunting for many 
of our students. 
ApprOXimately three quarters of medical students grad­
uate with debt, and more tha n half of these students leave 
with debt exceeding $100,000. Similarly, the average debt 
of students graduating from the Programs in Audiology 
and Communication Sciences, PhYSical Therapy and 
Occupational Therapy exceeds $85,000 - a burden made 
more severe by an average profeSSional salary of $50,000. 
Second-year medical student Lucy Zhang was at a 
tipping pOint. Faced with a choice of schools that were 
affordable but not a great fit and schools that were desirable 
but unaffordable, scholarships made the difference. "Having 
to take on less debt during my medical education eliminates 
many stresses and affords me the opportunity to explore 
various fields of medicine," Zhang says. 
Similarly, Washington University School of Medicine 
stands at a tipping point. TIle Scholarship Initiative can 
provide necessary resources that will enable the School of 
Medicine to sustain its momentum well into the future. "We 
have incredible students at Washington UniverSity School 
of Medicine who graduate with a Significant debt load," says 
Shapiro, "and we are compelled to alleviate this burden." 
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BY GWEN ERICSONgratefulpatient 
Linda and Harvey Saligman 
Taking research to the next level 

H rvey Saligman, a St. Louis­
area priva te investor, was in 
New York for a business t ri p 

when suddenly his hip began hurting. 

The pain was severe and persistent. 

"I was having great difficulty walking," 

Saligman says. "I had always prided 

myself that I could walk to almost 

anything, but I had to hire a car to get 

around because my leg hurt so badly." 

Back home in St. Louis, Saligman 
was diagnosed with multiple myeloma, 
a type of blood cancer that originates 
in the bone marrow. He came to the 
School of Medicine for care under 
myeloma speciali st Ravi Vij, MD, 
associate professor of medici ne in the 
Division of Oncology. 
Today, Saligman is in remission , 
but the experience inspired a new ven­
ture . He and his wife, Linda , talked 
about how they could make a differ­
ence to others faci ng myeloma. 
"Having been associated with the 
university for more than 20 years, 
I know it has great physic ians and 
researchers," Saligman says. He has 
served as a member of the Washington 
University Board of Trustees since 
1986 and has been on the Washington 
University School of Medicine 
National Council since the mid-1990s. 
"Linda and I saw that other places 
were better known for myeloma 
research , but we thought, why not 
here?" he says. "So with the goal of 
moving the university to the fore ­
front in myeloma research, we set up 
a fund, and we hope it will attract 
additional support." 
The Harvey and Linda Saligman 
Multiple Myeloma Research Fund will 
support basic and clinical research in 
the Div is ion of Oncology to under­
stand the causes of myeloma and to 
develop improved treatments and 
ultimately a cure for the disease. 
"We are at a critical point and ready 
to go from a local and regional center 
to a national myeloma center," says 
divi sion director John F. DiPersio, MD, 
PhD, the Lewis T. and Rosa lind B. 
Apple Chair in Oncology. "We have a 
nationally and internationally recog­
nized clinical program now fu r ther 
strengthened by strong bas ic science 
focused on the biology and genomics 
of myeloma. But to go to the next level, 
we need community philanthropic 
support ; that will make the difference." 
The division conducts a number 
of clinical studies to evaluate new 
myeloma treatments, many of which 
Vij heads. Washington University is 
a member of the Multiple Myeloma 
Research Consortium, an organ ization 
of 13 lead ing U.S. academic centers 
designed to speed development of 
new myeloma therapies. As a mem­
ber, the medical school can prov ide 
patients access to new medications that 
wouldn 't otherwise be available. 
"Mu ltiple myeloma is rapidly 
undergOing a therapeutic revolution," 
John F. DiPersio, MD, PhD, left, 
Harvey Saligman and Ravi Vij, MD 
Vij says. "We have already made great 
strides in improving the life expec­
tancy of myeloma patients and hope 
that we can someday come up with 
curative therapies." 
At the basic-science level , three 
key resea rch areas contribute to the 
invest igation of myeloma at the School 
of Medicine. Researchers tap into the 
rise of genome science and the pres­
ence of the Genome Center to identify 
the genetic abnormalities th at initiate 
the disease and contribute to its pro­
gression. They also study the effect of 
novel compounds in laboratory models 
of myeloma and conduct re search in 
basic bone biology to find out how to 
prevent bone damage from myeloma. 
Other projects look into myeloma 
incidence and distribution to isolate 
the disease's risk factors. 
Ultimately, generosity such as 
the Saligmans' will move this critical 
research forward, helping Washington 
University School of Medicine to 
quickly develop a leading program 
for multiple myeloma research . 















APRIL 29 - MAY 1 
Reunion 2010 is right around the corner, with an exciting new schedule of events! You will have an opportunity to take CME courses offered by fellow alumni and 
current faculty members. There will be trips to the St. Louis Zoo, the Science Center 
and the Missouri Botanical Garden. You can enjoy ajog through Forest Park and take 
in aCards game! And of course, you will have the opportunity to reconnect with 
classmates at the Friday night class parties and the Saturday night Alumni Banquet. 
Look for registration materials in January 2010, 
or talk to a member of your Reunion Class Committee. 
The School ofMedicine is aided in its Reunion planning by many loyal alumni. We are grateful 
to the following individuals who have volunteered to make the 2070 event a special weekend. 
Robert Drews, MD 55 F. Thomas Ott, MD 65 James Fleshman, MD 80 
John Martin, MD 55 Margaret Telfer, MD 65 Thomas Loeb, MD 80 
E. Robert Schultz, MD 55 Donald Anderson, MD 70 Bert Mandelbaum, MD 80 
Nathan Simon, MD 55 William Blair, MD 70 William Morgan, MD 80 
W. Yates Trotter, M D 55 William Blattner, MD 70 David Mutch, MD 80 
Miles Whitener, MD 55 Joann Data, MD 70 Herluf Lund Jr., MD 85 
Floyd Bloom, M D 60 Marilyn Escobedo, MD 70 Paul Miller, MD 90 
Paula Clayton, MD 60 Francisco Garriga, MD 70 Linda Peterson, MD 90 
Robert Edmonds, MD 60 Scot Hickman, MD 70 Martha Terry, MD 95 
David Rosenbaum, MD 60 Paul Mennes, MD 70 Po Wei Wang, MD 95 
Gustav Schonfeld, MD 60 David Ortbals, MD 70 Michael Kappelman, MD 00 
Eli Shuter, MD 60 William Shearer, MD 70 Michael Peelie, MD 00 
Gabriel Zatlin, MD 60 David Clifford, MD75 Clare Pipkin, MD 00 
James Louie, MD 65 Jo-Ellyn Ryall, MD 75 Geoffrey Uy, MD 00 
James Marks, MD 65 Robert Cooper, MD 80 Erik Wallace, MD 00 
~ For more details on MD Reunion 2010, visit: medicalalumnLwustl.edu ~ 
classnotes 
1940s 
Morris Alex, MD 43 
Alex is retired and resides in St. Louis MO. 
He enjoys writing and consulting 
for ALU Social Security. He is most proud 
of his children, grandchildren and great­
grandchildren. 
Sarah Arpe Malin, MD 48 
Malin, who is retired from pediatrics, is 
an active member of hospice. Her late 
husband was Jacob Malin, MD 48. She 
is a member of the North Lake Tahoe 
Historical Society, as well as the American 
Association of University Women. She 
enjoys studying French and exercising 
daily. Malin resides in Kings Beach CA. 
1950s 
Lowell A. Gess, MD 51 
Gess retired as a misSionary with United 
Methodist Committee of Relief (UMCOR) 
as a member of the General Board of 
Global Ministries in 1975. He first traveled 
to Africa as an eye surgeon in 1953 with 
his wife, Ruth, a registered nurse, and their 
four children. He has remained involved 
with three eye hospitals in Sierra Leone, 
Nigeria and Zimbabwe for many years and 
is thrilled that all of them are doing well 
with excellent staff. He had the opportu­
nity to visit the Kissy United Methodist 
Eye Hospital in Sierra Leone in April and 
May of 2009, where it was rewarding to 
see the highly trained ophthalmologist 
at Kissy providing the best eye care in 
the least developed country of the world. 
Gess currently resides in Alexandria MN. 
William Shieber, MD 53 
Shieber has retired from surgery and lives 
in St. Louis MO with his wife, Horty. He 
plays golf in his spare time and enjoys 
being a docent at the Saint Louis Zoo. 
1960s 
Robert Hunt, MD 63 
Hunt is retired. As he reflects on his surgi­
cal career, he is most proud of his devel­
opment of a breast care diagnostic and 
treatment center. In hisspare time, he likes 
to travel, play golf and read. He resides in 
Cape Girardeau MO with his wife, Sue. 
Edgar C. Boedeker, MD 68 
Boedeker left the University of Maryland 
and moved to Placitas NM where he is a 
professor of medicine at the University 
of New Mexico. He enjoys sailing when 
he visits Maryland. He is a member of the 
American Society for Microbiology. 
2nd Century Award recipients: Gerald Medoff, MD 62,Ieft, Doris Schnuck and Carl Frieden, PhD. 
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Bela S. Denes, MD 73 
After practicing urology for 23 years, 
Denes joined the pharmaceutical industry. 
Currently head of urology drug develop­
ment for Spectrum Pharmaceuticals in 
Irvine CA, he also has provided urology 
services at clinics for the indigent in 
Orange County. He resides in Laguna 
Beach CA. 
Robert Schmitz, MD 78 
In 1985, Schmitz left medicine to pursue 
a career in real estate. He is married to 
Amy Csorba, MD, who practices family 
medicine. They have three children and 
reside in Durham NC. 
1980s 
Mark Boothby, MD 83 
Boothby is a professor in the Department 
of Microbiology and Immunology at 
Vanderbilt University School of Medicine. 
In recent years, he has published many 
research articles. He also has stayed 
funded, taught students, and had lots 
of great times with his family. He resides 
in Nashville TN with his wife, Jin Chen, 
and their son. 
2nd Century Awards 
The 2009 2nd Century Awards were 
presented at a dinner held at the Ritz­
Carlton Hotel in Clayton MO on October 3. 
The awards, bestowed annually since 1991, 
mark Washington University School of 
Medicine's entry into its second century 
of leadership in patient care, teaching 
and research. The 2nd Century Award 
recognizes individuals whose long-term 
commitment and participation truly have 
made a difference, enabling the School 
of Medicine to look to the future with 
strength and confidence. 
Winter 2009 
Janie Cox, MD 83 
Cox recently retired so that she can spend 
more time with her children and volunteer 
in their schools. She loves her time with 
her family; they often go hiking and 
camping. Cox resides in Portland OR. 
Eric Stevens, MD 86 
Stevens is a member of a 12-person 
pulmonary, critical care and sleep medi­
cine group in loveland and Fort Collins CO. 
He is married and has two girls, ages 14 
and 10. He enjoys cycling, rowing and 
playing bass guitar. 
1990s 
Peter M. Bridge, MD 93 
Bridge is a private practice plastic surgeon. 
He spends his free time reading, traveling 
and swimming. He resides in Temple 
Terrace FL with his wife, Donna, and his 
two sons, Holden and Blake. 
Lynne Champagne, MD 93 
Champagne has a private practice in 
internal medicine. She works a reduced 
schedule in order to spend time with her 
young children. She lives in San Diego CA 
with her husband, Wilfred Kearse. 
Pablo Adler, MD 98 
Adler is the director of education for the 
Department of Anesthesia at Christian 
Care Health System. He resides in 
Wilmington DE with his wife, Christina. 
He enjoys lifting weights, martial arts, 
traveling and seeing his kids grow. 
2000s 
Cynthia Chiu, OT 04 
Chiu recently returned to St. Louis from 
Kansas City KS to be closer to family. 
She has two small children: Lucas, 2, and 
Peter, 1. She resides in Kirkwood MO. 
Beth Schukman Daze, PT 06 
Daze, who works at an outpatient physical 
therapy clinic in Raytown MO, recently was 
promoted to clinic manager. She enjoys 
her new position and looks forward to 
many years within the same company. She 
was married on May 9, 2009, and bought a 
house in Kansas City KS this past summer. 
outlook.wustl.edu 
IN MEMORY 
Marjorie S. Dunlap, NU 42 
Dunlap died in Santa Rosa CA on July 20, 
2009, at age 91. She was a professor and 
dean of nursing at the University of Hawaii 
and at the University of California-San 
Francisco, from which she retired in 1982. 
Elmer LeVerl Barrett, MD 43 
Barrett died at home on Aug. 27, 2009, 
at the age of 93. He liked to note that he 
practiced internal medicine in an era when 
doctors took phone calls and made house 
calls; his medical training also coincided 
with the introduction of antibiotics when, 
as he said, "people who used to die lived:' 
Phillip Comens, MD 51 
Comens died on January 9, 2009, at his 
home in Sunset Hills MO. He was 85. 
An assistant professor of medicine at 
Washington University School of Medicine, 
he carried out extensive research in hyper­
tension and cardiology before going into 
private practice. He also was a flight sur­
geon with the Missouri National Guard. 
Clifton Brooks Sr., HS 52 
Brooks died on May 8, 2009, in Norman 
OK at the Oklahoma Veterans Center. After 
graduating from Washington University 
School of Medicine, he attended UCLA, 
completing a masters degree in public 
health. His military service spanned 
34 years and three branches of the mili­
tary. He enjoyed his life and family, was an 
Eagle Scout and a Past Master of lexington 
lodge #72, and spent many hours 
researching family genealogy. 
Rhys A. Williams, MD 53 
Williams died on April 19, 2009, in 
San Antonio TX. He practiced general 
surgery for 32 years at the North Arkansas 
Medical Center, from which he retired in 
1991 . He and his wife, Bina, then moved to 
Aspen CO. He was a medical expert for the 
Social Security Administration until shortly 
before his death. 
John G. Durham, DE 56 
Durham died on Aug. 20, 2009, after a 
nine-year struggle with cancer. He was 78. 
An assistant professor of clinical dentistry 
at Washington University, he ran a private 
general dentistry practice for 50 years. 
Marshal Glyn Maggard, HA 60 
Maggard died on March 17, 2009. He 
worked as an assistant administrator at 
Hillcrest Medical Center in Tulsa OK, then 
later as CEO of Galesburg Cottage Hospital 
in Galesburg Il, until he retired in 1983. 
FACULTY 
M. Kenton King, MD 
King, dean of Washington University 
School of Medicine for nearly 25 years, 
died on Oct. 15, 2009, at his home in 
University City MO. He was 84. He was 
one of the longest-serving medical deans 
in the United States, as well as one of the 
most successful. Under his guidance, the 
School of Medicine became one of the 
foremost institutions of medical educa­
tion in the world. Through his leadership 
and vision, in particular his instrumental 
role in recruiting new heads of all medical 
school departments, he shaped the course 
of the institution. He also championed a 
dramatic change in the composition of the 
student body, recruiting more minority 
and women students. During his tenure, 
the school's campus grew tremendously, 
and he worked to strengthen the amount 
and quality of research and to bolster 
alumni relations. He is survived by his wife, 
June Greenfield King, a 1951 graduate 
of the Washington University School of 
Nursing, four sons and eight grandchil­
dren. He was preceded in death by a fifth 
son, Washington University alumnus and 
University City Police Sergeant Michael 
King, who was killed while on duty in 2008. 
Lee N. Robins, PhD 
Robins, professor emeritus of social science 
in psychiatry at Washington University 
School of Medicine, died peacefully at 
home on Sept. 25, 2009, following a long 
battle against cancer. She was 87. A world 
leader in psychiatric epidemiology research, 
she had worked in the Department of 
Psychiatry for more than 50 years. She is 
survived by husband Hugh Chaplin Jr., MD, 
an emeritus professor in the Departments 
of Medicine and Pathology and the former 
head of the Irene Walter Johnson Institute 
of Rehabilitation, four sons, eight grand­




Your School ofMedicine 
Include abequest in your estate. 
Consider providing a bequest that will support future 
programs or endow a professorship, scholarship or 
research fund in your name or that of a family member. 
Call (314) 935-5373 or (800) 835-3503 
For more information, complete the reply card 
or e-mail us at plannedgiving@wustl,edu. 
Visit our web site: plannedgiving.wustl,edu 
Seek advice from your tax or legal adviser when (onsidering a bequest. 
DON AND MARY HARKNESS, 
both MD 58, have established 
an endowed scholarship fund 
in memory of their daughter, 
Laurel, with current gifts and 
abequest in their estate plan. 
Laurel Harkness, MD 86, 
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I,earn n10 lbout vour 0 to tran~tonn lnedi,:in 
T here are many ways you can make a gift to Washington University School of Medicine. Your giving 
supports endeavors that benefit human 
health, and we can help you match your 
personal philanthropic goals with 
academic priorities. 
If you wish to make a gift or request more 
information, please complete and return 
this card. Or call the Office of Medical 
Alumni and Development at (314) 935-9691 
for a personal consultation. Thank you for 
your interest and ongoing support of the 
School's vital mission. 
GIVING OPPORTUNITIES 
I am interested in supporting Washington University 
School ofMedicine. Please send information about: 
o 	Unrestricted Fund for the School of Medicine 
This gift will be used to su pport priorities at the 
School of Medicine. 
o 	Scholarships: Opening Doors to the Future 
The scholarsh ip initiat ive that helps today's students 
become tomorrow 's medical professionals. 
o 	BioMed 21 
BioMed 21 is a cu tting-edge, multidisciplinary effort 
to rapidly translate the discoveries of basic science 
into cl inica l care. 
o 	Specific Department/Division 
o Specific Program 
o Specific Physician/Researcher/Professor 
o Other 
GIFT ATTRIBUTION 
o 	I wish to make a Memorial gift. 
o 	I wish to make an Anonymous gift. 
GIVING OPTIONS 
o 	Gift Annuity 
Please provide information about gift annuities to 
benefi t Washington Universi ty School of Medicine. 
o 	Estate Plan 
o 	Cash 
o 	Securities 





State 	 Zip _____________ 
Daytime Phone _____________________ 
E-mail_ _________________________ 
IiJWashingtonUniversity inSt.lDuis· Schoolof Medicine medschool. wustl.edu 
Fold this form and seal edges with tape to mail. 
~Washington





UNITED STATES SCHOOL OF MEDICINE 
BUSINESS REPLY MAIL 

FIRST-CLASS MAIL PERMIT NO 685 ST LOUIS MO 
POSTAGE WILL BE PAID BY ADDRESSEE 
MEDICAL ALUMNI & DEVELOPMENT PROGRAMS 
WASHINGTON UNIVERSITY IN ST LOUIS 
CAMPUS BOX 1247 
7425 FORSYTH AVE 
ST LOUIS MO 63105-9403 
1.11 •••• 11 •••• 1111 •••• 1.1.1.1 ••• 1•• 111 ••••• 11.1.1 •• 1 

CODE C STAFF 
MR PHILIP JAMES SKROSKA 
CAMPUS BOX: 8132 
